Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic investigation of moxifloxacin penetration into pericardial effusion
2007-006051-39Phase 3Terminated
- Sponsor
- Philipps-Universität Marburg
- Start
- Feb 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of moxifloxacin in pericardial effusion, pericarditis and malignant pericardial effusion (MPE), sponsored by Philipps-Universität Marburg. Primary endpoints: Moxifloxacin concentration in pericardial effusion and Moxifloxacin concentration in serum. Started Feb 2009; status: terminated.
02
Drugs
moxifloxacin
03
Conditions
pericardial effusionpericarditismalignant pericardial effusion (MPE)
Beyond the preview
Go deeper on 2007-006051-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006051-39.